Dorizoe Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-05-2024
- Paid Up Capital ₹ 0.73 M
as on 02-05-2024
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2017
- Revenue 20.86%
(FY 2017)
- Profit 128.29%
(FY 2017)
- Ebitda -51.22%
(FY 2017)
- Net Worth 12.12%
(FY 2017)
- Total Assets 104.74%
(FY 2017)
About Dorizoe Lifesciences
- CIN/LLPIN
U24239GJ2011PLC065289
- Company No.
065289
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
04 May 2011
- Date of AGM
29 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Dorizoe Lifesciences Limited offer?
Dorizoe Lifesciences Limited offers a wide range of products and services, including Corporate and Soft Skills Training, Corporate Training, Pharma & Bioanalytical Services, Pharmaceutical Services, Turnkey Consultants & Solutions, Project Management.
Who are the key members and board of directors at Dorizoe Lifesciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arjun Handa  | Director | 15-Jun-2017 | Current |
| Shyamsunder Sharma | Director | 15-Jun-2017 | Current |
| Amitbhai Tandon | Director | 27-Apr-2017 | Current |
| Jayesh Joshi | Director | 04-Jul-2017 | Current |
Financial Performance and Corporate Structure Insights of Dorizoe Lifesciences.
Dorizoe Lifesciences Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 20.86% increase. The company also saw a substantial improvement in profitability, with a 128.29% increase in profit. The company's net worth Soared by an impressive increase of 12.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dorizoe Lifesciences?
In 2017, Dorizoe Lifesciences had a promoter holding of 99.88% and a public holding of 0.12%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dorizoe Lifesciences?
Dorizoe Lifesciences has a workforce of 55 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dorizoe Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dorizoe Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
